Sub • Stance | Peptides: What Nobody Selling Or Regulating Them Will Tell You
The Heavy Meta PodcastShow Notes
A peptide is legal or illegal depending on a court calendar, not a toxicology report.
In September 2024 Eli Lilly sued the FDA over whether retatrutide contains 40 amino acids or 41 — a dispute worth seven extra years of market exclusivity, four extra years of protection from Medicare price negotiation, and the exclusive right to a molecule succeeding a $36.5 billion franchise. Nobody in that case argues the molecule is more dangerous one way or the other.
Eight days before I recorded this, Lilly filed six federal lawsuits against peptide sellers and disclosed it had referred more than 200 individuals and entities to regulators and licensing boards.
This episode is about how to think about that — and about what's actually in the vial, which is a separate problem with worse numbers.
Covered: — The retatrutide classification fight and what a biologic designation actually buys — Lilly's August 2026 lawsuits and enforcement referrals — Why psychedelics started moving the month they became ownable — What the FDA's 503A changes in April and July did and didn't do — Independent testing on gray-market peptides: 41.6–71.1% failure rates, 15% endotoxin — Why a certificate of analysis tells you almost nothing — Where peptide knowledge actually came from (Duchaine 1981, Bhasin 1996) — BPC-157 versus the loading protocol people skip to afford it — PRP: your own blood, and it still doesn't beat saline — Immunogenicity, mast cells, and why the reaction shows up on dose eight — Why we test before anything: attribution, not accuracy — The four gates we require before prescribing
DISCLOSURE: I have a financial interest in Alqemis, a functional diagnostics practice that can prescribe peptides. My wife Erin runs the diagnostics side. Nothing in this video is medical advice. I'm not a physician, I'm not diagnosing or treating anyone, and I'm not telling you to start or stop anything. Those decisions belong with a licensed prescriber who knows your history.
Full written version: https://www.weareheavymeta.com/articles/the-peptide-fence Work with Erin: https://calendar.app.google/DgkVXyF4HPs9dWhZ7
CHAPTERS 0:00 The same fact, two verdicts 2:11 Where I stand 2:56 The fence: one molecule that isn't an amino acid 4:39 What a biologic designation actually buys 6:27 The August lawsuits 7:53 The black market is a real problem 8:55 July said one thing, August said another 10:11 The fifty-year version of this 11:15 Schedule One was a social finding 12:13 What we did to them, and what might fix it 12:49 Lilly buys the toad 14:02 Legality tracks ownership 14:15 What actually changed in 2026 15:30 What independent testing found 16:37 Why a certificate of analysis tells you nothing 18:06 The supply chain nobody mentions 18:43 Who pays for the news 19:33 Where this knowledge came from 20:48 The gyms were right by forty years 22:58 If you're the study, be the instrument 23:21 BPC-157 24:00 What the tendon research actually says 25:14 You can't inject a change into the cause 26:06 PRP: your own blood, and still no better than saline 27:24 Whoever picks the comparator picks the answer 28:16 What you're injecting into 29:13 Mast cells, histamine, DAO 30:04 Why it happens on dose eight 30:40 You're an experiment either way 31:49 The cost of knowing yourself 32:25 What happens when the evidence arrives 33:50 The evidence got better, the practice got worse 34:03 Four gates 35:18 Close 36:58 Everything I've tried
SOURCES Eli Lilly & Co. v. FDA, No. 1:24-cv-01503 (S.D. Ind.); Seventh Circuit appeal Lilly enforcement actions, August 12 2026 (six federal complaints) FDA interim 503A bulk drug substances list, April 2026; PCAC meeting July 23–24 2026 Evaluation of research-grade peptides marketed direct-to-consumer (6,441 samples, 14 compounds) Venhuis et al., JMIR 2024 — online semaglutide vendor purity analysis FDA API facility registration data; USP API supply-chain analysis Duchaine, The Underground Steroid Handbook (1981) Bhasin et al., NEJM 335(1), 1996 Living
More from The Heavy Meta Podcast
Just after first light they heard the terrorists praying for the first time all night. Christian Craighead told the Kenyans to get ready, then started singing the Hail Mary. On "amen," four grenades came down the stairs.
He's inside 14 Riverside Drive alone. His own side is planning his court-martial. Nobody sends him maps, mug shots, or orders — and 150 people are hiding in a hair salon.
In January 2019, an SAS operator walked alone into a terrorist attack on the DusitD2 hotel complex in Nairobi. More than 700 people got out alive. Then his name started disappearing from the coverage.
Endurance is not a pace. It's not a zone. It's not a finish line. Endurance is how long you can keep going, and almost nothing we call endurance training is training that. Three of us rode 575 miles in 24 hours on an assault bike. I was back on the bike within days. One of us took months. One of us never rode again. Same event, same night, same wattage. The outcome had nothing to do with how fast we went. In this episode: Endurance is defined by duration, not intensity. The word comes from the Latin durus, hard, the same root as durable and duration. Most "endurance events" are speed tests over a fixed distance, which means the training gets built backward from speed and the last-place finisher is usually the most enduring person in the field. Endurance works like strength: there's a boundary, you expand it by getting close to it repeatedly, and you don't cross it. Crossing is how endurance athletes end their careers and call it burnout. Why I would not have made myself hate bike racing. 27 hours a week, 70 races a season, 305 watts for three hours. I could go fast. I couldn't keep going. The Space Race. How three people with five weeks of prep and no base rode 575 miles on the advice of Race Across America record holders: pulls as short as possible, 60 seconds on, two minutes off, for 14 hours. Why the tortoise and the hare is the wrong moral. Neither slow-and-steady nor fast-and-talented answers the question, because in real endurance there is no finish line. Why I'm close to pulling MAF from the Heavy Meta Endurance program. Not because Maffetone is wrong, but because any method that designates a pace gives you a number to chase, and the session becomes about the number instead of the time. The Double-It Test. At the halfway point, ask if you could double the distance without changing pace. If yes, you're not touching the boundary. Go further. If no, ask if you picked too hard a pace. That's the whole program. Optimal is whatever keeps you going. Not this session. Over your life. The day you quit enduring is the day you die. This is the difference between finite-game fitness, training to a line, and infinite-game fitness, training to keep going. The Heavy Meta Endurance program is built on the second one. Twelve weeks, long low-end work, short top-end work, no pace prescriptions. I just finished it myself. No numbers. I go longer and I still want to. CHAPTERS 0:00 Endurance is not a pace 0:47 The question I didn't want to answer 1:36 Endure, durable, duration 2:58 The boundary you approach and don't cross 4:05 The Space Race 6:23 450 watts against my entire life 7:52 My answer to Derek 9:46 575 miles and only one of us came back 10:57 The tortoise and the hare are both wrong 11:40 Why MAF designates a speed 12:57 The Double-It Test 13:52 Optimal is whatever keeps you going 14:51 Twelve weeks, zero numbers Read the article: https://www.weareheavymeta.com/articles/if-you-are-not-going-longer-you-are-not-training-endurance Heavy Meta membership: weareheavymeta.com Heavy Meta is an online training membership built on the Constraint Method: strength, speed, power, endurance, and mobility trained together, for life, not for an event. #endurance #zone2 #polarizedtraining #assaultbike #heavymeta #constraintmethod
Style is identity made visible. Most men dress in a way that communicates nothing, because they'd rather be invisible than be a liar with their appearance.